IBO·45259L205·US·equity·Healthcare - Biotechnology-Activist
IBO (IMPACT BIOMEDICAL INC) is held by 12 institutional investors as of Q1 2026. Largest holders: GEODE CAPITAL MANAGEMENT, LLC ($716,246), STATE STREET CORP ($364,738), BlackRock, Inc. ($155,968). Net institutional sentiment: Mixed.
See how IBO's score breaks down across 4 SEC sources
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer